Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunovant Inc (NQ: IMVT )

14.68 +0.81 (+5.84%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 2, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 819,133
Open 13.90
Bid (Size) 14.32 (3)
Ask (Size) 14.73 (1)
Prev. Close 13.87
Today's Range 13.67 - 14.71
52wk Range 3.145 - 14.71
Shares Outstanding 114,998,871
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
What 6 Analyst Ratings Have To Say About Immunovant
Within the last quarter, Immunovant (NASDAQ:IMVT) has observed the following analyst ratings: 
Via Benzinga
6 Analysts Have This to Say About Immunovant
Over the past 3 months, 6 analysts have published their opinion on Immunovant (NASDAQ:IMVT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga

Performance

YTD
+67.39%
+67.39%
1 Month
+31.90%
+31.90%
3 Month
+170.85%
+170.85%
6 Month
+224.06%
+224.06%
1 Year
+85.12%
+85.12%

More News

Read More
Where Immunovant Stands With Analysts
Via Benzinga
Immunovant to Present at Guggenheim 4th Annual Immunology and Neurology Day on November 14th
From Immunovant Inc.
Via Globe NewsWire
Immunovant: Q2 Earnings Insights
Via Benzinga
Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended September 30, 2022
From Immunovant Inc.
Via Globe NewsWire
Why Immunovant Stock Is Skyrocketing This Week
Via The Motley Fool
Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
Via Benzinga
Why Sotera Health Shares Are Trading Lower By Around 13%, Here Are 38 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
RPM International, Lamb Weston And Some Other Big Stocks Moving Higher On Wednesday
Via Benzinga
R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing
Via FinancialNewsMedia
Topics Death
Exposures Death
S&P 500 Rises 100 Points; Nasdaq Up 3%
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nasdaq Surges 350 Points; Crude Oil Rises Sharply
Via Benzinga
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
Via Benzinga
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
How Is The Market Feeling About Immunovant?
Via Benzinga
Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Enerpac Tool Group, Wix.com And Some Other Big Stocks Moving Higher On Thursday
Via Benzinga
UBS Slashes PT On This Stock By Over 89%? Plus Evercore ISI Group Predicts $150 For First Solar
Via Benzinga
Why Sunlight Financial Shares Are Trading Lower By 59%, Here Are 54 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022
Via Benzinga
This Analyst Slashes PT On Lyft By 68%, Plus Telsey Advisory Group Predicts $125 For Nike
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.